These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 22582882

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Development of a novel direct compressible co-processed excipient and its application for formulation of Mirtazapine orally disintegrating tablets.
    Loke YH, Chew YL, Janakiraman AK, Lee SK, Uddin ABMH, Goh CF, Kee PE, Ng HS, Ming LC, Liew KB.
    Drug Dev Ind Pharm; 2024 Jan; 50(1):36-44. PubMed ID: 38149637
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A new formulation for orally disintegrating tablets using a suspension spray-coating method.
    Okuda Y, Irisawa Y, Okimoto K, Osawa T, Yamashita S.
    Int J Pharm; 2009 Dec 01; 382(1-2):80-7. PubMed ID: 19686825
    [Abstract] [Full Text] [Related]

  • 7. Preparation and characterization of a novel co-processed excipient of chitin and crystalline mannitol.
    Daraghmeh N, Rashid I, Al Omari MM, Leharne SA, Chowdhry BZ, Badwan A.
    AAPS PharmSciTech; 2010 Dec 01; 11(4):1558-71. PubMed ID: 21052880
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Polyols as filler-binders for disintegrating tablets prepared by direct compaction.
    Bolhuis GK, Rexwinkel EG, Zuurman K.
    Drug Dev Ind Pharm; 2009 Jun 01; 35(6):671-7. PubMed ID: 19274511
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of co-processed excipients used for direct compression of orally disintegrating tablets (ODT) using novel disintegration apparatus.
    Brniak W, Jachowicz R, Krupa A, Skorka T, Niwinski K.
    Pharm Dev Technol; 2013 Jun 01; 18(2):464-74. PubMed ID: 22881600
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation of Loratadine Orally Disintegrating Tablets by Semi-solid Extrusion 3D Printing.
    Yi S, Xie J, Chen L, Xu F.
    Curr Drug Deliv; 2023 Jun 01; 20(6):818-829. PubMed ID: 36221886
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of co-processed excipient type on properties of orodispersible tablets containing captopril, tramadol, and domperidone.
    Tranová T, Loskot J, Navrátil O, Brniak W, Mužíková J.
    Int J Pharm; 2023 Apr 05; 636():122838. PubMed ID: 36921743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development and optimization of dextromethorphan hydrobromide oral disintegrating tablets: effect of formulation and process variables.
    Mostafa HF, Ibrahim MA, Sakr A.
    Pharm Dev Technol; 2013 Apr 05; 18(2):454-63. PubMed ID: 22881389
    [Abstract] [Full Text] [Related]

  • 18. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S, Iwao Y, Kimura S, Itai S.
    Int J Pharm; 2011 Sep 15; 416(1):252-9. PubMed ID: 21763765
    [Abstract] [Full Text] [Related]

  • 19. Systematic screening of compressed ODT excipients: cellulosic versus non-cellulosic.
    Al-Khattawi A, Iyire A, Dennison T, Dahmash E, Bailey CJ, Smith J, Rue P, Mohammed AR.
    Curr Drug Deliv; 2014 Sep 15; 11(4):486-500. PubMed ID: 24655059
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.